33532620 34676827 31528845 30828530 34299321 34526227 32469143 35530146 33101031 33530432 34022200 34621170 35630058 32945868 31686320 31199058 33226340 34203309 34755470 32707695 33309965 29696816 29035693 34285405 34849563 31786336 30225759 3371883 - Search Results

Year	Number of Results
2017	1
2018	4
2019	6
2020	7
2021	16
2022	3

1

Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3.

Gusdon AM, Hui Y, Chen J, Mathews CE, Qu S. Gusdon AM, et al. Endocrinol Diabetes Metab. 2020 Oct 6;4(1):e00187. doi: 10.1002/edm2.187. eCollection 2021 Jan. Endocrinol Diabetes Metab. 2020. PMID: 33532620 Free PMC article.

2

ANT2 drives proinflammatory macrophage activation in obesity.

Moon JS, da Cunha FF, Huh JY, Andreyev AY, Lee J, Mahata SK, Reis FC, Nasamran CA, Lee YS. Moon JS, et al. JCI Insight. 2021 Oct 22;6(20):e147033. doi: 10.1172/jci.insight.147033. JCI Insight. 2021. PMID: 34676827 Free PMC article.

3

Knockdown of Ant2 Reduces Adipocyte Hypoxia And Improves Insulin Resistance in Obesity.

Seo JB, Riopel M, Cabrales P, Huh JY, Bandyopadhyay GK, Andreyev AY, Murphy AN, Beeman SC, Smith GI, Klein S, Lee YS, Olefsky JM. Seo JB, et al. Nat Metab. 2019 Jan;1(1):86-97. doi: 10.1038/s42255-018-0003-x. Epub 2018 Nov 19. Nat Metab. 2019. PMID: 31528845 Free PMC article.

4

Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases.

Yu Y, Cai J, She Z, Li H. Yu Y, et al. Adv Sci (Weinh). 2018 Dec 12;6(4):1801585. doi: 10.1002/advs.201801585. eCollection 2019 Feb 20. Adv Sci (Weinh). 2018. PMID: 30828530 Free PMC article. Review.

5

Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests.

Di Ciaula A, Calamita G, Shanmugam H, Khalil M, Bonfrate L, Wang DQ, Baffy G, Portincasa P. Di Ciaula A, et al. Int J Mol Sci. 2021 Jul 19;22(14):7702. doi: 10.3390/ijms22147702. Int J Mol Sci. 2021. PMID: 34299321 Free PMC article. Review.

6

Stress-induced FGF21 and GDF15 in obesity and obesity resistance.

Keipert S, Ost M. Keipert S, et al. Trends Endocrinol Metab. 2021 Nov;32(11):904-915. doi: 10.1016/j.tem.2021.08.008. Epub 2021 Sep 13. Trends Endocrinol Metab. 2021. PMID: 34526227 Review.

7

CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.

Li H, Shi X, Jiang H, Kang J, Yu M, Li Q, Yu K, Chen Z, Pan H, Chen W. Li H, et al. J Cell Mol Med. 2020 Jul;24(13):7417-7426. doi: 10.1111/jcmm.15357. Epub 2020 May 29. J Cell Mol Med. 2020. PMID: 32469143 Free PMC article.

8

NF-κB regulates brown adipocyte function through suppression of ANT2.

Peng S, Zhang X, Yu L, Xu Y, Zhou Y, Qian S, Cao X, Ye X, Yang J, Jia W, Ye J. Peng S, et al. Acta Pharm Sin B. 2022 Mar;12(3):1186-1197. doi: 10.1016/j.apsb.2021.10.023. Epub 2021 Oct 29. Acta Pharm Sin B. 2022. PMID: 35530146 Free PMC article.

9

Mitochondrial Energy-Regulating Effect of Atractyloside Inhibits Hepatocellular Steatosis Through the Activation of Autophagy.

Zhang P, Li L, Sun H, Zhang Y, Zhang G, Zhang T, Zeng C. Zhang P, et al. Front Pharmacol. 2020 Sep 30;11:575695. doi: 10.3389/fphar.2020.575695. eCollection 2020. Front Pharmacol. 2020. PMID: 33101031 Free PMC article.

10

Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy.

Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H. Arroyave-Ospina JC, et al. Antioxidants (Basel). 2021 Jan 26;10(2):174. doi: 10.3390/antiox10020174. Antioxidants (Basel). 2021. PMID: 33530432 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results